| Trial registration number
|
NCT04643054 |
Full text link
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04643054
|
First author
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Antonio Cascio, MD, PhD
|
Contact
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
antonio.cascio03@unipa.it
|
Registration date
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2020-11-24
|
Recruitment status
Last imported at : Nov. 7, 2022, noon
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- positive swab test of sars-cov-2
- pneumonia related to sars-cov-2
- signature of informed consent
- absence of allergies to egg proteins
|
Exclusion criteria
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
- unsigned informed consent
- negative swab test of sars-cov-2
- allergy to egg proteins
- pregnancy and breastfeeding
- mechanical ventilation
|
Number of arms
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
|
Inclusion age min
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Italy
|
Type of patients
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
primary outcome
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
In-hospital mortality
|
Notes
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Nov. 26, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 941, "treatment_name": "Ovotransferrin", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|